Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srikala S Sridhar

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Journal of Oncology Practice|May 11, 2017
Evolving Treatment of Advanced Urothelial CancerSrikala S Sridhar
Breast Cancer : Basic and Clinical Research|March 23, 2012
Efficacy and tolerability of lapatinib in the management of breast cancerPunam Rana, Srikala S Sridhar
Molecular Cancer Therapeutics|May 11, 2012
New directions for biologic targets in urothelial carcinomaSuzanne Richter, Srikala S Sridhar
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Angiogenesis inhibitors under study for the treatment of lung cancerFrances A Shepherd, Srikala S Sridhar
Lung Cancer (Amsterdam, Netherlands)|November 13, 2003
Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancerSrikala S Sridhar, Frances A Shepherd
Therapeutic Advances in Medical Oncology|July 11, 2023
Clinical trial reform in the post-COVID eraMeghan E Mahoney, Srikala S Sridhar
Current Opinion in Supportive and Palliative Care|August 12, 2015
Options in metastatic urothelial cancer after first-line therapyNimira S Alimohamed, Srikala S Sridhar
Asia-Pacific Journal of Clinical Oncology|November 30, 2018
Prime time for immunotherapy in advanced urothelial cancerDi Maria Jiang, Srikala S Sridhar
Clinical Genitourinary Cancer|October 1, 2024
Prognostic Impact of Bone Metastasis in Patients With Metastatic Urothelial Carcinoma Treated With Durvalumab With or Without Tremelimumab in the DANUBE StudyCarlos Stecca, Osama Abdeljalil, Srikala S Sridhar
Seminars in Radiation Oncology|December 14, 2022
The Role of Neoadjuvant Chemotherapy in Bladder Preservation Approaches in Muscle-Invasive Bladder CancerCarlos Stecca, Timur Mitin, Srikala S Sridhar
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Journal of Oncology Practice|May 11, 2017
Evolving Treatment of Advanced Urothelial CancerSrikala S Sridhar
Breast Cancer : Basic and Clinical Research|March 23, 2012
Efficacy and tolerability of lapatinib in the management of breast cancerPunam Rana, Srikala S Sridhar
Molecular Cancer Therapeutics|May 11, 2012
New directions for biologic targets in urothelial carcinomaSuzanne Richter, Srikala S Sridhar
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Angiogenesis inhibitors under study for the treatment of lung cancerFrances A Shepherd, Srikala S Sridhar
Lung Cancer (Amsterdam, Netherlands)|November 13, 2003
Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancerSrikala S Sridhar, Frances A Shepherd
Therapeutic Advances in Medical Oncology|July 11, 2023
Clinical trial reform in the post-COVID eraMeghan E Mahoney, Srikala S Sridhar
Current Opinion in Supportive and Palliative Care|August 12, 2015
Options in metastatic urothelial cancer after first-line therapyNimira S Alimohamed, Srikala S Sridhar
Asia-Pacific Journal of Clinical Oncology|November 30, 2018
Prime time for immunotherapy in advanced urothelial cancerDi Maria Jiang, Srikala S Sridhar
Clinical Genitourinary Cancer|October 1, 2024
Prognostic Impact of Bone Metastasis in Patients With Metastatic Urothelial Carcinoma Treated With Durvalumab With or Without Tremelimumab in the DANUBE StudyCarlos Stecca, Osama Abdeljalil, Srikala S Sridhar
Seminars in Radiation Oncology|December 14, 2022
The Role of Neoadjuvant Chemotherapy in Bladder Preservation Approaches in Muscle-Invasive Bladder CancerCarlos Stecca, Timur Mitin, Srikala S Sridhar
Pageof 15